Table of Contents
Executive Summary
1 Industry Overview of Sunitinib Malate
1.1 Definition of Sunitinib Malate
1.2 Sunitinib Malate Segment by Type
1.2.1 Global Sunitinib Malate Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Purity: >99%
1.2.3 Purity: >98%
1.2.4 Purity: >97%
1.3 Sunitinib Malate Segment by Applications
1.3.1 Global Sunitinib Malate Consumption Comparison by Applications (2014-2025)
1.3.2 Pancreatic Neuroendocrine Tumors
1.3.3 Kidney Cancer
1.3.4 Gastrointestinal stromal tumor
1.4 Global Sunitinib Malate Overall Market
1.4.1 Global Sunitinib Malate Revenue (2014-2025)
1.4.2 Global Sunitinib Malate Production (2014-2025)
1.4.3 North America Sunitinib Malate Status and Prospect (2014-2025)
1.4.4 Europe Sunitinib Malate Status and Prospect (2014-2025)
1.4.5 China Sunitinib Malate Status and Prospect (2014-2025)
1.4.6 Japan Sunitinib Malate Status and Prospect (2014-2025)
1.4.7 Southeast Asia Sunitinib Malate Status and Prospect (2014-2025)
1.4.8 India Sunitinib Malate Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Sunitinib Malate
2.3 Manufacturing Process Analysis of Sunitinib Malate
2.4 Industry Chain Structure of Sunitinib Malate
3 Development and Manufacturing Plants Analysis of Sunitinib Malate
3.1 Capacity and Commercial Production Date
3.2 Global Sunitinib Malate Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Sunitinib Malate
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Sunitinib Malate Production and Capacity Analysis
4.2 Sunitinib Malate Revenue Analysis
4.3 Sunitinib Malate Price Analysis
4.4 Market Concentration Degree
5 Sunitinib Malate Regional Market Analysis
5.1 Sunitinib Malate Production by Regions
5.1.1 Global Sunitinib Malate Production by Regions
5.1.2 Global Sunitinib Malate Revenue by Regions
5.2 Sunitinib Malate Consumption by Regions
5.3 North America Sunitinib Malate Market Analysis
5.3.1 North America Sunitinib Malate Production
5.3.2 North America Sunitinib Malate Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Sunitinib Malate Import and Export
5.4 Europe Sunitinib Malate Market Analysis
5.4.1 Europe Sunitinib Malate Production
5.4.2 Europe Sunitinib Malate Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Sunitinib Malate Import and Export
5.5 China Sunitinib Malate Market Analysis
5.5.1 China Sunitinib Malate Production
5.5.2 China Sunitinib Malate Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Sunitinib Malate Import and Export
5.6 Japan Sunitinib Malate Market Analysis
5.6.1 Japan Sunitinib Malate Production
5.6.2 Japan Sunitinib Malate Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Sunitinib Malate Import and Export
5.7 Southeast Asia Sunitinib Malate Market Analysis
5.7.1 Southeast Asia Sunitinib Malate Production
5.7.2 Southeast Asia Sunitinib Malate Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Sunitinib Malate Import and Export
5.8 India Sunitinib Malate Market Analysis
5.8.1 India Sunitinib Malate Production
5.8.2 India Sunitinib Malate Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Sunitinib Malate Import and Export
6 Sunitinib Malate Segment Market Analysis (by Type)
6.1 Global Sunitinib Malate Production by Type
6.2 Global Sunitinib Malate Revenue by Type
6.3 Sunitinib Malate Price by Type
7 Sunitinib Malate Segment Market Analysis (by Application)
7.1 Global Sunitinib Malate Consumption by Application
7.2 Global Sunitinib Malate Consumption Market Share by Application (2014-2019)
8 Sunitinib Malate Major Manufacturers Analysis
8.1 Pfizer
8.1.1 Pfizer Sunitinib Malate Production Sites and Area Served
8.1.2 Pfizer Product Introduction, Application and Specification
8.1.3 Pfizer Sunitinib Malate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Topcarepharm
8.2.1 Topcarepharm Sunitinib Malate Production Sites and Area Served
8.2.2 Topcarepharm Product Introduction, Application and Specification
8.2.3 Topcarepharm Sunitinib Malate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Njfirstpharm
8.3.1 Njfirstpharm Sunitinib Malate Production Sites and Area Served
8.3.2 Njfirstpharm Product Introduction, Application and Specification
8.3.3 Njfirstpharm Sunitinib Malate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 J&K Scientific
8.4.1 J&K Scientific Sunitinib Malate Production Sites and Area Served
8.4.2 J&K Scientific Product Introduction, Application and Specification
8.4.3 J&K Scientific Sunitinib Malate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Targetmol
8.5.1 Targetmol Sunitinib Malate Production Sites and Area Served
8.5.2 Targetmol Product Introduction, Application and Specification
8.5.3 Targetmol Sunitinib Malate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
9 Development Trend of Analysis of Sunitinib Malate Market
9.1 Global Sunitinib Malate Market Trend Analysis
9.1.1 Global Sunitinib Malate Market Size (Volume and Value) Forecast 2019-2025
9.2 Sunitinib Malate Regional Market Trend
9.2.1 North America Sunitinib Malate Forecast 2019-2025
9.2.2 Europe Sunitinib Malate Forecast 2019-2025
9.2.3 China Sunitinib Malate Forecast 2019-2025
9.2.4 Japan Sunitinib Malate Forecast 2019-2025
9.2.5 Southeast Asia Sunitinib Malate Forecast 2019-2025
9.2.6 India Sunitinib Malate Forecast 2019-2025
9.3 Sunitinib Malate Market Trend (Product Type)
9.4 Sunitinib Malate Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Sunitinib Malate Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
【掲載企業】
Pfizer、Topcarepharm、Njfirstpharm、J&K Scientific、Targetmol